Bionovo (BNVI) Reports Q3 Loss of $0.05
Bionovo Inc. (NASDAQ: BNVI) reports Q3 EPS of $0.05 loss, in-line analyst estimate of ($0.05). Revenue for the quarter was $155K
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Tiffany & Co. (TIF) Misses Q1 EPS Views; Lowers FY12 EPS, Revs Growth Outlook
- PVH Corp. (PVH) Tops Q1 EPS by 4c; Guides FY12 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
